Published • loading... • Updated
Bonehead out of Oasis tour after cancer diagnosis
- Paul 'Bonehead' Arthurs, Oasis guitarist, announced on October 3, 2025, he is taking a planned break from the reunion tour due to health reasons.
- He revealed an earlier diagnosis of prostate cancer this year and had previously been treated for tonsil cancer in 2022, with the all-clear confirmed last September.
- Arthurs will miss the forthcoming concerts across key cities in Asia and Australia as he continues his medical treatment but took part in the initial portion of the tour and plans to rejoin the band for the South American leg beginning November 15.
- He mentioned that his treatment is going well, he feels positive overall, and though he's disappointed to miss some performances, he expects to return to performing live with the band during their South American tour soon.
- Oasis expressed support, wishing him well and confirming his return, while the band recently completed the UK leg with two Wembley shows and plans to perform in Asia, Australia, and South America.
Insights by Ground AI
90 Articles
90 Articles
Oasis guitarist Paul 'Bonehead' Arthurs has announced that he will not be taking part in a planned tour of South Korea, Japan and Australia due to health reasons. The 60-year-old, who has prostate cancer, assured fans that he is otherwise feeling well and will be ready to return to the stage by the time the tour moves to South America.
·Ljubljana, Slovenia
Read Full Article
Through a statement on his social networks, Paul 'Bonehead' Arthurs, Oasis guitarist, said he will take a break from the tour
·Los Angeles, United States
Read Full Article
Oasis guitarist Paul Arthurs is pausing his current tour for health reasons. The 60-year-old musician, also known as Bonehead, is undergoing cancer treatment.
·Amsterdam, Netherlands (Kingdom of the)
Read Full Article
Coverage Details
Total News Sources90
Leaning Left18Leaning Right12Center29Last UpdatedBias Distribution49% Center
Bias Distribution
- 49% of the sources are Center
49% Center
L 31%
C 49%
R 20%
Factuality
To view factuality data please Upgrade to Premium
